GlaxoSmithKline plc (ADR)  

(Public, NYSE:GSK)   Watch this stock  
Find more results for GSK
-0.01 (-0.02%)
Real-time:   10:26AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 45.42 - 45.58
52 week 41.25 - 55.37
Open 45.54
Vol / Avg. 735,055.00/3.86M
Mkt cap 109.63B
P/E 6.89
Div/yield 0.58/5.56
EPS 6.61
Shares 4.86B
Beta 0.65
Inst. own 5%
Jul 29, 2015
Q2 2015 GlaxoSmithKline PLC Earnings Release - 3:00AM EDT - Add to calendar
May 7, 2015
GlaxoSmithKline PLC Annual Shareholders Meeting (Estimated)
May 7, 2015
GlaxoSmithKline PLC Annual Shareholders Meeting
May 6, 2015
Q1 2015 GlaxoSmithKline PLC Investor Event
May 6, 2015
Q1 2015 GlaxoSmithKline PLC Earnings Release
May 6, 2015
Q1 2015 GlaxoSmithKline PLC Pre-Recorded Earnings Presentation
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 142.97% 12.31%
Operating margin 178.92% 15.64%
EBITD margin - 28.70%
Return on average assets 65.37% 6.84%
Return on average equity 554.76% 48.95%
Employees 98,702 -
CDP Score - 96 B


980 Great West Road
United Kingdom - Map
+44-20-80475000 (Phone)
+44-20-80477807 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


GlaxoSmithKline plc. (GSK) is a healthcare company. GSK develops pharmaceutical, vaccine and consumer healthcare products. The pharmaceuticals business develops and makes medicines to treat a range of acute and chronic diseases. The vaccines business produces paediatric and adult vaccines against a range of infectious diseases. GSK’s Consumer Healthcare business is structured around four categories: Total Wellness, Oral Care, Nutrition and Skin Health. For Pharmaceuticals and Vaccines, GSK operates in geographical segments that combine these two businesses, namely United States Pharmaceuticals and Vaccines, Europe Pharmaceuticals and Vaccines, Emerging Markets and Asia Pacific (EMAP) Pharmaceuticals and Vaccines, and Japan Pharmaceuticals and Vaccines. Its Consumer Healthcare business functions as a global unit, as does ViiV Healthcare, a human immunodeficiency virus (HIV) company founded by GSK along with Pfizer and Shionogi. In addition, it owns the biological conjugation platform.

Officers and directors

Andrew Philip Witty Chief Executive Officer, Executive Director
Age: 50
Bio & Compensation  - Reuters
Simon Dingemans Chief Financial Officer, Executive Director
Age: 51
Bio & Compensation  - Reuters
Moncef Slaoui Chairman - Global Vaccines, Executive Director
Age: 55
Bio & Compensation  - Reuters
Roger Connor President - Global Manufacturing & Supply
Bio & Compensation  - Reuters
Shah Abbas Hussain President - Europe, Japan & EMAP
Age: 49
Bio & Compensation  - Reuters
Patrick Vallance President - Pharmaceuticals R&D
Bio & Compensation  - Reuters
Emma Walmsley President - Consumer Healthcare Worldwide
Bio & Compensation  - Reuters
Daniel Troy Senior Vice President, General Counsel
Bio & Compensation  - Reuters
Claire Thomas Senior Vice President - Human Resources
Bio & Compensation  - Reuters
Bill Louv Senior Vice President - Core Business Services
Bio & Compensation  - Reuters